Anizatrectinib
Anizatrectinib (hTrkA-IN-1) is a potent and orally active inhibitor of TrkA kinase with an IC50 of 1.3 nM, compound 2 extracted from patent WO2015175788. Anizatrectinib can be used for the study of inflammatory disease, such as prostatitis, pelvic, et al.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 1824664-89-2
- Fòrmula: C29H32FN7O2
- Peso molecular:529.61
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
|
TrkA |
Chemical Information
-
No. CAS 1824664-89-2
-
Peso molecular 529.61
-
Fòrmula C29H32FN7O2
-
SMILES
O=C(NC1=C(C)C(C2=CN=C(C)N=C2)=NN1C3=CC=CC=C3)N[C@@H]4CN(CCOC)C[C@H]4C5=CC=CC(F)=C5
-
Synonyms
hTrkA-IN-1
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)